Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
State epidemiologist briefs committee on COVID trends, vaccine trials and distribution planning
Summary
Arkansas Department of Health epidemiologist Dr. Jennifer Dillehay updated the committee on rising COVID-19 cases, hospitalizations and the state’s vaccine planning. She summarized vaccine candidate types, trial phases, cold‑chain logistics (noting Pfizer’s −70°C requirement), prioritization guidance and the department’s intent to submit a vaccination plan to CDC.
Dr. Jennifer Dillehay, state epidemiologist for the Arkansas Department of Health, briefed the Senate Public Health, Welfare and Labor Committee on national vaccine development efforts and Arkansas’s readiness to receive and distribute doses.
Dillehay reported the state had recorded more than 95,000 confirmed COVID-19 cases and about 1,600 deaths, with roughly 8,000 active cases and elevated hospitalizations (about 587 in hospital as of the prior day). She outlined how vaccine development works — Phase 1 safety, Phase 2 effectiveness, and larger Phase 3 trials — and explained why multiple…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
